Clinical Trial Update: HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

View source ↗

Summary

The HEPFER trial evaluating a new phenotypic biological marker in genetic-type 1 hereditary hemochromatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Snippet

Sponsor: Rennes University Hospital | Conditions: Hereditary Hemochromatosis C282Y Homozygous | Status: COMPLETED